Retrospective analysis of changing characteristics of treatment-seeking smokers

Implications for further reducing smoking prevalence

Teresa M. Leyro, Erin E. Crew, Susan W. Bryson, Anna Lembke, Steffani Bailey, Judith J. Prochaska, Lisa Henriksen, Stephen P. Fortmann, Joel D. Killen, Diana T. Killen, Sharon M. Hall, Sean P. David

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: The goal of the current study was to empirically compare successive cohorts of treatmentseeking smokers who enrolled in randomised clinical trials in a region of the USA characterised by strong tobacco control policies and low smoking prevalence, over the past three decades. Design: Retrospective treatment cohort comparison. Setting: Data were collected from 9 randomised clinical trials conducted at Stanford University and the University of California, San Francisco, between 1990 and 2013. Participants: Data from a total of 2083 participants were included (Stanford, n=1356; University of California San Francisco, n=727). Primary and secondary outcomes: One-way analysis of variance and covariance, χ2 and logistic regression analyses were used to examine relations between nicotine dependence, cigarettes per day, depressive symptoms and demographic characteristics among study cohorts. Results: Similar trends were observed at both settings. When compared to earlier trials, participants in more recent trials smoked fewer cigarettes, were less nicotine-dependent, reported more depressive symptoms, were more likely to be male and more likely to be from a minority ethnic/racial group, than those enrolled in initial trials (all p's

Original languageEnglish (US)
Article number010960
JournalBMJ Open
Volume6
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

San Francisco
Tobacco Products
Randomized Controlled Trials
Smoking
Depression
Tobacco Use Disorder
Nicotine
Ethnic Groups
Tobacco
Analysis of Variance
Cohort Studies
Logistic Models
Regression Analysis
Demography
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Retrospective analysis of changing characteristics of treatment-seeking smokers : Implications for further reducing smoking prevalence. / Leyro, Teresa M.; Crew, Erin E.; Bryson, Susan W.; Lembke, Anna; Bailey, Steffani; Prochaska, Judith J.; Henriksen, Lisa; Fortmann, Stephen P.; Killen, Joel D.; Killen, Diana T.; Hall, Sharon M.; David, Sean P.

In: BMJ Open, Vol. 6, No. 6, 010960, 01.06.2016.

Research output: Contribution to journalArticle

Leyro, TM, Crew, EE, Bryson, SW, Lembke, A, Bailey, S, Prochaska, JJ, Henriksen, L, Fortmann, SP, Killen, JD, Killen, DT, Hall, SM & David, SP 2016, 'Retrospective analysis of changing characteristics of treatment-seeking smokers: Implications for further reducing smoking prevalence', BMJ Open, vol. 6, no. 6, 010960. https://doi.org/10.1136/bmjopen-2015-010960
Leyro, Teresa M. ; Crew, Erin E. ; Bryson, Susan W. ; Lembke, Anna ; Bailey, Steffani ; Prochaska, Judith J. ; Henriksen, Lisa ; Fortmann, Stephen P. ; Killen, Joel D. ; Killen, Diana T. ; Hall, Sharon M. ; David, Sean P. / Retrospective analysis of changing characteristics of treatment-seeking smokers : Implications for further reducing smoking prevalence. In: BMJ Open. 2016 ; Vol. 6, No. 6.
@article{823f5e8e0d6349dcae563c51bbf77ff8,
title = "Retrospective analysis of changing characteristics of treatment-seeking smokers: Implications for further reducing smoking prevalence",
abstract = "Objective: The goal of the current study was to empirically compare successive cohorts of treatmentseeking smokers who enrolled in randomised clinical trials in a region of the USA characterised by strong tobacco control policies and low smoking prevalence, over the past three decades. Design: Retrospective treatment cohort comparison. Setting: Data were collected from 9 randomised clinical trials conducted at Stanford University and the University of California, San Francisco, between 1990 and 2013. Participants: Data from a total of 2083 participants were included (Stanford, n=1356; University of California San Francisco, n=727). Primary and secondary outcomes: One-way analysis of variance and covariance, χ2 and logistic regression analyses were used to examine relations between nicotine dependence, cigarettes per day, depressive symptoms and demographic characteristics among study cohorts. Results: Similar trends were observed at both settings. When compared to earlier trials, participants in more recent trials smoked fewer cigarettes, were less nicotine-dependent, reported more depressive symptoms, were more likely to be male and more likely to be from a minority ethnic/racial group, than those enrolled in initial trials (all p's",
author = "Leyro, {Teresa M.} and Crew, {Erin E.} and Bryson, {Susan W.} and Anna Lembke and Steffani Bailey and Prochaska, {Judith J.} and Lisa Henriksen and Fortmann, {Stephen P.} and Killen, {Joel D.} and Killen, {Diana T.} and Hall, {Sharon M.} and David, {Sean P.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1136/bmjopen-2015-010960",
language = "English (US)",
volume = "6",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Retrospective analysis of changing characteristics of treatment-seeking smokers

T2 - Implications for further reducing smoking prevalence

AU - Leyro, Teresa M.

AU - Crew, Erin E.

AU - Bryson, Susan W.

AU - Lembke, Anna

AU - Bailey, Steffani

AU - Prochaska, Judith J.

AU - Henriksen, Lisa

AU - Fortmann, Stephen P.

AU - Killen, Joel D.

AU - Killen, Diana T.

AU - Hall, Sharon M.

AU - David, Sean P.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Objective: The goal of the current study was to empirically compare successive cohorts of treatmentseeking smokers who enrolled in randomised clinical trials in a region of the USA characterised by strong tobacco control policies and low smoking prevalence, over the past three decades. Design: Retrospective treatment cohort comparison. Setting: Data were collected from 9 randomised clinical trials conducted at Stanford University and the University of California, San Francisco, between 1990 and 2013. Participants: Data from a total of 2083 participants were included (Stanford, n=1356; University of California San Francisco, n=727). Primary and secondary outcomes: One-way analysis of variance and covariance, χ2 and logistic regression analyses were used to examine relations between nicotine dependence, cigarettes per day, depressive symptoms and demographic characteristics among study cohorts. Results: Similar trends were observed at both settings. When compared to earlier trials, participants in more recent trials smoked fewer cigarettes, were less nicotine-dependent, reported more depressive symptoms, were more likely to be male and more likely to be from a minority ethnic/racial group, than those enrolled in initial trials (all p's

AB - Objective: The goal of the current study was to empirically compare successive cohorts of treatmentseeking smokers who enrolled in randomised clinical trials in a region of the USA characterised by strong tobacco control policies and low smoking prevalence, over the past three decades. Design: Retrospective treatment cohort comparison. Setting: Data were collected from 9 randomised clinical trials conducted at Stanford University and the University of California, San Francisco, between 1990 and 2013. Participants: Data from a total of 2083 participants were included (Stanford, n=1356; University of California San Francisco, n=727). Primary and secondary outcomes: One-way analysis of variance and covariance, χ2 and logistic regression analyses were used to examine relations between nicotine dependence, cigarettes per day, depressive symptoms and demographic characteristics among study cohorts. Results: Similar trends were observed at both settings. When compared to earlier trials, participants in more recent trials smoked fewer cigarettes, were less nicotine-dependent, reported more depressive symptoms, were more likely to be male and more likely to be from a minority ethnic/racial group, than those enrolled in initial trials (all p's

UR - http://www.scopus.com/inward/record.url?scp=84978091892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978091892&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2015-010960

DO - 10.1136/bmjopen-2015-010960

M3 - Article

VL - 6

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 6

M1 - 010960

ER -